References
- Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369:32–42.
- Wang ML, Rule S, Martin P, et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med. 2013;369:507–516.
- Chamilos G, Lionakis MS, Kontoyiannis DP. Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways. Clin Infect Dis. 2018;66:140–148.
- Ghez D, Calleja A, Protin C, et al. Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib. Blood. 2018;131:1955–1959.
- Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–2390.
- Duma N, Paludo J, Kabat B, et al. Invasive aspergillosis in chronic lymphocytic leukemia: therapy and outcomes. Blood. 2017;130:4327.
- Grommes C, Younes A. Ibrutinib in PCNSL: the curious cases of clinical responses and aspergillosis. Cancer Cell. 2017;31:731–733.
- Lionakis MS, Dunleavy K, Roschewski M, et al. Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma. Cancer Cell. 2017;31:833–843.
- Mehrotra A, Lieberman J, Legro IR, et al. Chronic pulmonary aspergillosis in a patient with splenectomy. Am J Med. 2018;131:e141–e142.
- Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest. 2002;122:302–310.
- Le Moing V, Lortholary O, Timsit JF, et al. Aspergillus pericarditis with tamponade: report of a successfully treated case and review. Clin Infect Dis. 1998;26:451–460.
- Kupsky DF, Alaswad K, Rabbani BT. A rare case of aspergillus pericarditis with associated myocardial abscess and echocardiographic response to therapy. Echocardiography. 2016;33:1085–1088.
- Nivoix Y, Velten M, Letscher-Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis. 2008;47:1176–1184.